Successful Settlement in $400 Million Qui Tam Case
Successfully negotiated a no admission of liability settlement on behalf of a pharmaceutical company in connection with a civil False Claims Act matter investigated by the U.S. Attorney’s Office for the Eastern District of Pennsylvania. The case originated from a qui tam complaint where the government initially sought damages well in excess of $400 million. The case was resolved for approximately 4% of the initial damages assessment, and a Corporate Integrity Agreement was reached with Department of Health and Human Services Office of Inspector General (HHSOIG) that avoided any debarment or exclusion sanctions.
